Fatty acid based hyperbranched polymeric nanoparticles for hydrophobic drug delivery

Drug Development and Industrial Pharmacy

Volumn 36, Issue 10, 2010, Pages 1139-1148

  Güç, Esra ^a   Günüdz, Güngör ^a   Gündüz, Ufuk ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Controlled drug delivery; Hyperbranched polymer; Idarubicin; Nanoparticle; Tamoxifen

Indexed keywords

CARBON 13; CYTOTOXIC AGENT; DIMETHYLOLPROPIONIC ACID; DIPENTAERYTHRITOL; DODECYL SULFATE SODIUM; ERYTHRITOL; FATTY ACID; IDARUBICIN; NANOPARTICLE; PROPIONIC ACID; RESIN; RICINOLEIC ACID; TAMOXIFEN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; MOLECULAR WEIGHT; PSEUDOMONAS;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DELAYED-ACTION PREPARATIONS; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FATTY ACIDS; FEMALE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IDARUBICIN; LIPASE; NANOPARTICLES; POLYMERS; RICINOLEIC ACIDS; TAMOXIFEN;

EID: 77956409541     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639041003691906     Document Type: Article

References (27)

1. Brannon-Peppas L, Blanchette JO. (2004). Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev, 56:1649-59.
2. Nori A, Kopecek J. (2005). Intracellular targeting of polymerbound drugs for cancer chemotherapy. Adv Drug Deliv Rev, 57:609-36.
3. Gupta U, Agashe HB, Asthana A, Jain NK. (2006). Dendrimers: Novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules, 7:649-58.
4. Paleos CM, Tsiourvas D, Sideratou Z. (2007). Molecular engineering of dendritic polymers and their application as drug and gene delivery systems. Mol Pharm, 4:169-88.
5. Bharathi P, Moore JS. (2000). Controlled synthesis of hyperbranched polymers by slow monomer addition to core. Macromolecules, 33:3212-8.
6. Sokolsky-Papkov M, Shikanov A, Kumar N, Vaisman B, Domb AJ. (2008). Fatty acid based biodegradable polymers-synthesis and applications. Bull Israel Chem Soc, 23:12-7.
7. Jain JP, Modi S, Kumar N. (2008). Hydroxy fatty acid based polyanhydride as drug delivery system: Synthesis, characterization, in vitro degradation, drug release, and biocompatibility. J Biomed Mater Res, 84:740-52.
8. Blasiak J, Gloc E, Warszawski M. (2002). A comparison of the in vitro genotoxicity of anticancer drugs idarubicin and mitoxantrone. Acta Biochim Pol, 49(1):145-55.
9. Bhatia A, Singh B, Singh B, Bhushan S, Katare OP. (2009). Tamoxifen-encapsulated vesicular systems: Cytotoxicity evaluation in human epidermal keratinocyte cell line. Drug Dev Ind Pharm, iFirst:1-5.
10. Long BJ, Jelovac D, Handratta V, Thiantanawat A, MacPherson N, Ragaz J, et al. (2004). Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model. J Natl Cancer Inst, 96:456-65.
11. Fukushima T, Inoue H, Takemura H, Kishi S, Yamauchi T, Inai K, et al. (1998). Idarubicin and idarubicinol are less affected by topoisomerase II-related multidrug resistance than is daunorubicin. Leuk Res, 22:625-9.
12. Bat E, Gündüz G, Kisakürek D, Akhmedov IM. (2005). Synthesis and characterization of hyperbranched and air drying fatty acid based resins. Prog Org Coating, 55:330-6.
13. Chawla JS, Amiji MM. (2002). Biodegradable poly(e-caprolactone) nanoparticles for tumor targeted delivery of tamoxifen. Int J Pharm, 249:127-38.
14. Hu FX, Neoh KG, Kang ET. (2006). Synthesis and in vitro anticancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials, 27:5725-33.
15. Tayade PL, Kale RD. (2004). Encapsulation of water insoluble drug by a cross-linking technique: Effect of process and formulation variables on encapsulation efficiency, particle size, and in vitro dissolution rate. AAPS Pharm Sci, 6:1-8.
16. Vishnu YV, Chandrasekhar K, Ramesh G, Rao YM. (2007). Development of mucoadhesive patches for buccal administration of carvedilol. Curr Drug Deliv, 4:27-39.
17. Dong Y, Feng SS. (2004). Methoxy poly(ethylene glycol) poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials, 25:2843-9.
18. Yu L, Zhang H, Cheng SX, Zhuo RX, Li H. (2006). Study on the drug release property of cholesteryl end-functionalized poly(epsilon-caprolactone) microspheres. J Biomed Mater Res B Appl Biomater, 77(1):39-46.
19. Maillard S, Ameller T, Gauduchon J, Gougelet A, Gouilleux F, Legrand P, et al. (2005). Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of antiestrogens in human breast cancer and multiple myeloma. J Steroid Biochem Mol Biol, 94:111-21.
20. Chu H, Liu N, Wang X, Jiao Z, Chen Z. (2009). Morphology and in vitro release kinetics of drug-loaded micelles based on welldefined PMPC-b-PBMA copolymer. Int J Pharm, 371:190-6.
21. Duerr-Auster N, Eisele T, Wepf R, Gunde R, Windhab EJ. (2008). Influence of pH on colloidal properties and surface activity of polyglycerol fatty acid ester vesicles. J Colloid Interface Sci, 327:446-50.
22. Ameller T, Marsaud V, Legrand P, Gref R, Barratt G, Renoir JM. (2003). Polyester-poly(ethylene glycol) nanoparticles loaded with the pure antiestrogen RU 58668: Physicochemical and opsonization properties. Pharm Res, 20:1063-70.
23. Cavallaro G, Maniscalco L, Licciardi M, Giammona G. (2004). Tamoxifen-loaded polymeric micelles: Preparation, physicochemical characterization and in vitro evaluation studies. Macromol Biosci, 4:1028-38.
24. Calil MR, Gaboardi F, Bardi MAG, Rezende ML, Rosa DS. (2007). Enzymatic degradation of poly (å-caprolactone) and cellulose acetate blends by lipase and á-amylase. Polym Test, 26(2): 257-61.
25. Ulbrich K, Subr V. (2004). Polymeric anti-cancer drugs with pH-controlled activation. Adv Drug Deliv Rev, 56:1023-50. (Pubitemid 38520207)
26. Zhang Z, Kuijer R, Bulstra SK, Grijpma DW, Feijen J. (2006). The in vivo and n vitro degradation behavior of poly(trimethylene carbonate). Biomaterials, 27:1741-48. (Pubitemid 41759468)
27. Vaulthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P. (2003). Drug delivery to resistant tumors: The potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release, 93:151-60.